Compare CSL & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSL | ELAN |
|---|---|---|
| Founded | 1917 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 12.4B |
| IPO Year | 1994 | 2018 |
| Metric | CSL | ELAN |
|---|---|---|
| Price | $353.03 | $24.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $401.67 | $27.89 |
| AVG Volume (30 Days) | 528.3K | ★ 6.8M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.27% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 9.37 | 0.22 |
| Revenue | ★ $5,003,600,000.00 | $4,715,000,000.00 |
| Revenue This Year | $2.59 | $8.21 |
| Revenue Next Year | $4.50 | $5.31 |
| P/E Ratio | ★ $36.76 | $110.09 |
| Revenue Growth | ★ 9.08 | 6.22 |
| 52 Week Low | $293.43 | $18.22 |
| 52 Week High | $432.91 | $27.98 |
| Indicator | CSL | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 42.53 | 49.54 |
| Support Level | $343.05 | $23.40 |
| Resistance Level | $345.63 | $25.77 |
| Average True Range (ATR) | 10.72 | 0.70 |
| MACD | -3.65 | 0.06 |
| Stochastic Oscillator | 30.74 | 49.03 |
Carlisle Companies Inc is a holding company that manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. It operates through two segments: Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The majority of revenue comes from Carlisle Construction Materials, and more than half of total revenue is earned in the United States. Carlisle Construction Materials produces premium single-ply roofing products and warranted roof systems, including EPDM, TPO, PVC membrane, and polyiso insulation. Carlisle Weatherproofing Technologies produces building envelope solutions, including waterproofing, moisture protection products, air/vapor barriers, and spray polyurethane foam systems.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, poultry, and swine production.